News
-
Drug Discovery: Alzheimer’s and Parkinson’s Spurred by Same Enzyme
(July 7, 2017) – Alzheimer’s disease and Parkinson’s disease are not the same. They affect different regions of the brain and have distinct genetic and environmental risk factors. But at the biochemical level, these two neurodegenerative diseases start …
-
Statins May Speed Symptoms of Onset Parkinson’s Disease in Some People
(June 26, 2017) – Researchers at Penn State College of Medicine found that statins may cause symptoms of onset Parkinson’s disease to advance more quickly in those who are susceptible to the disease, according to a new study published in Mo …
-
Autoimmunity May Have Role in Parkinson
(June 22, 2017) – For the first time, scientists have found evidence that autoimmunity may have a role in Parkinson’s disease. They found that fragments of the protein, alpha-synuclein that builds up in the dopamine cells of the brains of people with P …
-
Balance and Movement Improved in Animal Model of Parkinson’s Disease
(June 19, 2017) – Researchers at UCLA have developed a molecular compound that improves balance and coordination in mice with early stage Parkinson’s disease. Further, the drug, called CLR01, reduced the amount of a toxic protein in the brain tha …
-
Low-fat Dairy Intake May Raise Parkinson
(June 8, 2017) – According to a new study, consuming higher amounts of low-fat dairy may raise the risk of Parkinson’s disease. Researchers found that the risk of Parkinson’s disease was greater for adults who consumed at least three servings of …
-
Tom Isaacs, President of The Cure Parkinson
(June 1, 2017) – Tom Isaacs, co-founder and president of The Cure Parkinson’s Trust, passed away unexpectedly on May 31st at the age of 49. Read more…
-
Acorda Therapeutics to Present Update on Phase 3 Study of CVT-301 in Parkinson’s Patients
(May 22, 2017) – Acorda Therapeutics will soon release data on its Phase 3 trial investigating the experimental drug CVT-301 as a potential therapy for patients with Parkinson’s disease. Acorda will present its poster at the Inter …
-
Biomarkers for Cognitive Impairment in Parkinson
(May 19, 2017) – A new study based on research at the University of Pennsylvania suggests that the biomarkers identified could predict who among those diagnosed with PD will develop cognitive decline in the first 3 years after diagnosis. Should the res …
-
Team Parkinson Raised Over $113,000 at the 2017 Skechers Performance Los Angeles Marathon and LA BIG 5K in Support of Parkinson’s Disease Research
KINGSTON, N.J., May 18, 2017/ — The Parkinson Alliance announced today that Team Parkinson raised over $113,000 for our participation in the 2017 Skechers Performance Los Angeles Marathon as well as the LA BIG 5K. Held last March in Los Angeles, Calif …
-
Microsoft
(May 15, 2017) – At Build 2017, Microsoft unveiled a wearable device called ‘Emma.’ It is a wrist wearable that can help people living with Parkinson’s disease write and draw by reducing their tremors. The Emma Watch uses vibrating motors — …